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organizations who seek to challenge 
and raise awareness about the harms 
of the global pornography industry. 
Those who are familiar with 
contemporary feminist critiques of 
pornography are unlikely to find any-
thing ground-breaking in this text; 
however those who are new to the 
subject matter will find an accessible 
and engaging collection by contrib-
utors who are clearly informed and 
passionately invested in this area of 
research. Feminist proponents of por-
nography will certainly find reason to 
critique the text, as its contributors all 
but ignore the potential for women’s 
empowerment and agency in acting 
as producers and consumers of por-
nography. For their part, however, 
the contributors acknowledge this 
gap as they emphasize their intention 
to deconstruct and challenge the 
ideologies and socioeconomic con-
ditions that continue to normalize 
the selling and purchasing of women’s 
(or any feminized “others’”) bodies 
and sexualities. For these academics 
and activists, the potential for some 
women to act as empowered agents 
while producing and consuming 
pornography is not an adequate 
reason to withhold or dilute critique 
of the industry’s broader deleterious 
impacts.
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If you build it, she will come.
At least that’s the promise. That the 
pharmaceutical industry is driven 
by profit margins, above all else, is 
not news. And that there is (always) 
something wrong with women’s 
bodies requiring intervention hasn’t 
really lost any of its medical veracity. 
For in creating disorders, diseases, 
and panic, Big Pharma can swoop 
in with just the right treatment. For 
a price. The trouble is, it’s women 
again who pay most dearly when 
medicine and big business merge. Ray 
Moynihan and Barbara Mintzes have 
joined together to provide compelling 
evidence exposing pharmaceutical 
industry’s role in creating a disease 
that they then plan to cure. And 
what’s scary is that in just fifteen 
years, the mythic “Female Sexual 
Dysfunction” has gained inordinate 
popularity. Heck even Oprah quoted 
the industry-born and marketed “46 
percent of all women ‘suffer’ from 
fsd” stat. 
The pressure’s on ladies. And not in 
a good way and probably not on the 
right spot either. No, the pressure is 
on for you to want it more, and that 
you just aren’t ensuring he’s ringing 
your bell. Yup it’s your fault. And yes, 
I said he. You see same-sex sexuality 
isn’t important here—so much so it 
has been rendered invisible. Probably 
because women usually get it right 
for other women. But I digress…
Moynihan and Mintzes’ book Sex, 
Lies and Pharmaceuticals: How Drug 
Companies Plan to Profit from Female 
Sexual Dysfunction is a comprehensive 
investigation into this newly classified 
“problem” and the enormous push 
to place it in physicians’ professional 
vernacular. And just in time, because 
Flibanserin—a drug that promises to 
fix us—has just come on the market. 
Another drug to fix our inadequacies. 
Quel surprise. Moynihan and Mintz-
es’ research included interviews with 
retired pharmaceutical professionals 
who outed their own roles in the 
creation of fsd. In so doing, these 
courageous whistle-blowers assisted 
the authors to demonstrate how fsd 
is a grossly exaggerated phenomenon, 
barely earning the validity to be called 
a disorder in the first place. 
Moynihan has a rich history in this 
area, most recently documenting in 
Selling Sickness countless examples of 
the medicalization of every-day life 
phases which then require medical 
and pharmaceutical intervention. 
Now he is out to discredit the very 
basis for what’s being coined the 
Pink Viagra (again with the pink??), 
except it hasn’t worked. Early research 
has shown that unlike men, women 
don’t need more blood flow. And so 
the research has shifted. Up. Way up. 
Current research is exploring (brace 
yourselves) the usefulness of a pill 
targeting women’s brains. There it is 
again: the tie between women’s uterus 
and their minds. And of course the 
tie that binds is one of pathology. 
So not only are women too emo-
tional, too nervous, too fat, too 
irrational, and too dry, they’re not 
sexually responsive enough. Does this 
remind anyone else of the years when 
women were called frigid? Brrrrr. Has 
me shaking, but I’m not sure if it’s 
out of terror or anger. Probably both. 
But at least one thing has stayed 
constant. The real reason for women 
being unresponsive sexually aside 
from:
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 •being too tired; 
•made to feel ashamed about 
the appearance or scent of our 
bodies; 
•still reeling from a childhood 
or relational trauma; or
•exhausted from trying to be 
taken seriously; 
it’s the pervasive absence of any explo-
ration into the skill of her partner. So 
maybe instead of a pill, or a medical 
procedure to tighten her up, lift her 
bladder or re-boot her genito-urinary 
glands, would-be partners could be 
given a diagram of the clitoris’ loca-
tion. And at the top of the one-page 
précis should be this message:
“You Suck. And not in a good 
way.”
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Sexual Assault in Canada: Law, Legal 
Practice and Women’s Activism takes a 
comprehensive look at the socio-legal 
aspects of female sexual assault in 
Canada. More specifically, it looks 
at the variety of cultural myths and 
legal discourses and techniques that 
have historically helped with either 
denying its prevalence, normalizing 
it, preventing its prosecution, or 
portraying its harms as insignificant. 
This is an edited book of a massive 
proportion (819 pages) and an exten-
sive range. It is divided into two parts 
that contain a total of 28 articles. Part 
I, containing the first fifteen articles, 
examines sexual assault from a variety 
of points of views: various ways of 
discrediting (“unfounding”) of its 
reports by women by the criminal 
justice system officials, its promotion 
by the hyper-masculine sporting 
culture and other male-dominated 
institutions, the consequences of 
colonization and racism in its per-
petuation in regards to Aboriginal 
women, and its denial in relation 
to disabled women. It also looks at 
various forms of political pressure 
exerted on activists and sexual-assault 
centres to abandon feminist politics, 
and progressive forms of feminist art 
and literature that aim to subvert the 
traditional, legal discourses related 
to sexual assault. As a whole, these 
articles describe the cultural and legal 
realities surrounding sexual assault 
and point to theoretical and practi-
cal venues of resistance and change. 
The two most interesting papers in 
this part are those of McIntyre and 
Odette. In “The Supreme Court 
of Canada’s Betrayal of Residential 
School Survivors: Ignorance is No 
Excuse” McIntyre discusses the Su-
preme Court’s responses to compen-
sation claims by Aboriginal women 
and men who were sexually abused 
as children in residential schools. 
She argues that the Court ignored 
the extensive research on residential 
school abuse – which pointed to the 
racist social context as the main causes 
of such abuse – in its decisions and, 
instead, decided these cases using 
narrow and formalistic reasoning. 
In “Sexual Assault and Disabled 
Women Ten Years After Jane Doe” 
Odette examines barriers faced by 
disabled women who wish to resort 
to the legal system and/or various 
women’s centres. 
Part II, containing thirteen arti-
cles, focuses more on legal issues. 
The themes explored include pros-
ecution of sexual assault in relation 
to racialized women, adjudication 
of sexual assault and linguistic 
practices that embody rape myths, 
sexism, and other systemic obstacles 
facing women who testify in rape 
trials, sentencing of males convict-
ed of rape, and issues surrounding 
compensation for sexually assaulted 
women. Part II begins with Jane 
Doe’s “Who Benefits From the 
Sexual Assault Evidence Kit?”. It is 
based on interviews with women 
who have undergone Sexual Assault 
Evidence Kit (saek, which is the 
exam and treatment protocol and 
directions for evidence collection 
from sexually-assaulted women), 
nurses who administer saek, hospital 
counsellors, and sexual-assault crisis 
centres’ workers. Doe points to a 
gradual shift towards medicalization 
of sexual assault as an illness and the 
consequent increase in the power of 
medical officials as expressed in ad-
ministration of saek. She argues that 
inconsistent administration of saek, 
combined with its dubious legal util-
ity, has brought sexually-assaulted 
women little legal benefit and lots of 
psychological harm. The two most 
interesting papers in this part are 
those of Ehrlich and Marriner. Using 
linguistic analysis in “Perpetuating – 
and Resisting – Rape Myths in Trial 
Discourse”, Ehrlich demonstrates 
how the various forms of ques-
tioning techniques—for example, 
those demanding a yes/no answer, 
and those based on assumptions 
that the witness cannot reject if she 
answers the question—allow lawyers 
to control the kind of information 
